• Maze Therapeutics (NASDAQ:MAZE) Raised to Strong-Buy at Leerink Partnrs

    Source: Buzz FX / 26 Feb 2025 05:36:19   America/Chicago


    Maze Therapeutics (NASDAQ:MAZE) Raised to Strong-Buy at Leerink Partnrs Written by MarketBeat February 26, 2025 Share Link copied to clipboard. Maze Therapeutics ( NASDAQ:MAZE - Get Free Report ) was upgraded by Leerink Partnrs to a "strong
    Read more...
Share on,